Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Artrya Limited ( (AU:AYA) ) is now available.
Artrya Limited has announced the application for quotation of 100,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code AYA. This move signifies a strategic step in enhancing the company’s capital structure, potentially impacting its market positioning and providing new opportunities for stakeholders.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$3.51 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the healthcare industry, focusing on developing and providing advanced medical imaging solutions. The company’s primary product offerings include innovative diagnostic tools aimed at improving the detection and management of cardiovascular diseases, with a market focus on enhancing patient outcomes through technological advancements.
Average Trading Volume: 948,416
Technical Sentiment Signal: Buy
Current Market Cap: A$513.4M
Learn more about AYA stock on TipRanks’ Stock Analysis page.